Careers
Contact Us
Home
About Us
Vision, Values & Mission
Milestones
Leadership
Board of Directors
Management Team & Advisors
Scientific Advisors & Collaborators
Our People
Research
Research & Development
Our Strategic Approach
Opportunities
Clinical Studies
Publications
Products
NeuroAiD™ II
News
Partnering
Our Commercial Partners
Moleac Affiliates
Opportunities
TCM trial for stroke survivors
By
Saiful Najaib
July 31, 2014
August 3rd, 2017
News
No Comments
Search
Search
Recent Posts
Highlights from European Stroke Organisation Conference (ESOC) Scientific Symposium
Moleac holds two educational symposia on the management of Traumatic Brain Injury
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Stroke Recovery
NeuroAiD at ASEAN Neurological Association
Archives
June 2019
September 2018
March 2018
November 2017
October 2017
September 2017
May 2017
February 2017
January 2017
November 2016
June 2015
May 2015
July 2014
Categories
News
Share
Tweet
Share
Pin
Home
About Us
Vision, Values & Mission
Milestones
Leadership
Board of Directors
Management Team & Advisors
Scientific Advisors & Collaborators
Our People
Research
Research & Development
Our Strategic Approach
Opportunities
Clinical Studies
Publications
Products
NeuroAiD™ II
News
Partnering
Our Commercial Partners
Moleac Affiliates
Opportunities
